GB1592825A - Rubella virus immunoassay materials and methods for making and using same - Google Patents
Rubella virus immunoassay materials and methods for making and using same Download PDFInfo
- Publication number
- GB1592825A GB1592825A GB7901/78A GB790178A GB1592825A GB 1592825 A GB1592825 A GB 1592825A GB 7901/78 A GB7901/78 A GB 7901/78A GB 790178 A GB790178 A GB 790178A GB 1592825 A GB1592825 A GB 1592825A
- Authority
- GB
- United Kingdom
- Prior art keywords
- antigen
- rubella
- column
- eluted
- igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000710799 Rubella virus Species 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims description 34
- 239000000463 material Substances 0.000 title description 29
- 238000003018 immunoassay Methods 0.000 title description 5
- 239000000427 antigen Substances 0.000 claims abstract description 53
- 102000036639 antigens Human genes 0.000 claims abstract description 53
- 108091007433 antigens Proteins 0.000 claims abstract description 53
- 201000005404 rubella Diseases 0.000 claims abstract description 36
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 7
- 210000003743 erythrocyte Anatomy 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 10
- 230000000984 immunochemical effect Effects 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 12
- 238000012360 testing method Methods 0.000 abstract description 12
- 230000035931 haemagglutination Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 239000001963 growth medium Substances 0.000 abstract description 8
- 239000007790 solid phase Substances 0.000 abstract description 8
- 238000005227 gel permeation chromatography Methods 0.000 abstract description 7
- 230000004520 agglutination Effects 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 6
- 238000013375 chromatographic separation Methods 0.000 abstract description 5
- 230000001900 immune effect Effects 0.000 abstract description 3
- 239000011236 particulate material Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 4
- 239000000872 buffer Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000002609 medium Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 229920005654 Sephadex Polymers 0.000 description 5
- 239000012507 Sephadex™ Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 238000000760 immunoelectrophoresis Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960000359 chromic chloride Drugs 0.000 description 1
- LJAOOBNHPFKCDR-UHFFFAOYSA-K chromium(3+) trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cr+3] LJAOOBNHPFKCDR-UHFFFAOYSA-K 0.000 description 1
- 235000007831 chromium(III) chloride Nutrition 0.000 description 1
- 239000011636 chromium(III) chloride Substances 0.000 description 1
- -1 collodium Chemical compound 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/20—Rubella virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36251—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77323177A | 1977-03-01 | 1977-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1592825A true GB1592825A (en) | 1981-07-08 |
Family
ID=25097600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB7901/78A Expired GB1592825A (en) | 1977-03-01 | 1978-02-28 | Rubella virus immunoassay materials and methods for making and using same |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS53107414A (cs) |
| AU (1) | AU513684B2 (cs) |
| CA (1) | CA1087983A (cs) |
| CH (1) | CH639207A5 (cs) |
| DE (1) | DE2808615A1 (cs) |
| FR (1) | FR2382461A1 (cs) |
| GB (1) | GB1592825A (cs) |
| NL (1) | NL7802216A (cs) |
| SE (1) | SE7802069L (cs) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2217501C2 (ru) * | 2002-01-11 | 2003-11-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Набор олигонуклеотидов-праймеров для идентификации вируса краснухи |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2514367A1 (fr) * | 1981-10-08 | 1983-04-15 | Pasteur Institut | Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau |
| FI841094L (fi) * | 1984-03-19 | 1985-09-20 | Univ Tennesee Research Corp | Virusantigen bunden vid en baerare, dess framstaellning och anvaendning. |
| JPS6147566A (ja) * | 1984-08-13 | 1986-03-08 | Tetsuo Tomiyama | 抗風疹ウイルス抗体感作血球及びこれを用いる抗風疹ウイルス抗体の測定方法 |
| JPS6153569A (ja) * | 1984-08-24 | 1986-03-17 | Tetsuo Tomiyama | 抗風疹ウイルス抗体感作ラテツクス及びこれを用いる抗風疹ウイルス抗体の測定方法 |
| JPH03127305U (cs) * | 1990-04-04 | 1991-12-20 | ||
| JPH0412201U (cs) * | 1990-05-23 | 1992-01-31 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2111120C3 (de) * | 1970-03-11 | 1974-10-17 | Takeda Chemical Industries Ltd | Verfahren zur Herstellung von Rubella-Virus-Hämagglutinationsantigen |
-
1978
- 1978-02-10 CA CA296,720A patent/CA1087983A/en not_active Expired
- 1978-02-10 AU AU33181/78A patent/AU513684B2/en not_active Expired
- 1978-02-22 SE SE7802069A patent/SE7802069L/xx unknown
- 1978-02-28 DE DE19782808615 patent/DE2808615A1/de active Pending
- 1978-02-28 JP JP2170178A patent/JPS53107414A/ja active Granted
- 1978-02-28 CH CH214978A patent/CH639207A5/fr not_active IP Right Cessation
- 1978-02-28 NL NL7802216A patent/NL7802216A/xx not_active Application Discontinuation
- 1978-02-28 GB GB7901/78A patent/GB1592825A/en not_active Expired
- 1978-02-28 FR FR7805741A patent/FR2382461A1/fr not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2217501C2 (ru) * | 2002-01-11 | 2003-11-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Набор олигонуклеотидов-праймеров для идентификации вируса краснухи |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2808615A1 (de) | 1978-09-07 |
| NL7802216A (nl) | 1978-09-05 |
| AU513684B2 (en) | 1980-12-18 |
| AU3318178A (en) | 1979-08-16 |
| CH639207A5 (en) | 1983-10-31 |
| CA1087983A (en) | 1980-10-21 |
| SE7802069L (sv) | 1978-09-02 |
| FR2382461A1 (fr) | 1978-09-29 |
| JPS53107414A (en) | 1978-09-19 |
| JPS6231301B2 (cs) | 1987-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4195074A (en) | Process for producing a soluble rubella antigen | |
| US4343896A (en) | Method and test pack for the demonstration and determination of an antigen or antibody | |
| EP0466914B2 (en) | Immunochromatographic method | |
| US5506110A (en) | Carrier for binding of anti-phospholipid antibodies, and immunoassay method using the same and a kit therefor | |
| US4960715A (en) | Diagnostic test methods | |
| US3966898A (en) | Method and reagent for determining immunologic materials | |
| CA1275379C (en) | Method of detecting, isolating and purifying clostridium difficile toxin a and its receptors | |
| US4526871A (en) | Conjugate obtained by coupling a lectin and a specific ligand, containing such a conjugate and its applications in biology | |
| EP0051985B1 (en) | Immunoassay of proteins | |
| EP0064318B1 (en) | A method and a kit for the assay of antibodies to soluble antigens | |
| EP0185722A1 (en) | Polyclonal antibodies, preparation and use | |
| EP0064274A1 (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
| US6156524A (en) | Reagent for the detection of Staphylococcus aureus by agglutination | |
| EP0108992B1 (en) | Immunoassay | |
| EP0256117A1 (en) | Latex agglutination using avidin/biotin system | |
| GB1592825A (en) | Rubella virus immunoassay materials and methods for making and using same | |
| EP0079145B1 (en) | Reagent for use in diagnosis of syphilis and preparation thereof | |
| EP0928201B1 (en) | Novel glycolipid complexes and their uses | |
| US4178359A (en) | Immunoassay method | |
| US4757000A (en) | Process for assaying ATL virus antibody and reagent therefor | |
| AU779524B2 (en) | Assay | |
| EP0134868A1 (en) | Unicellular organisms activated by glutaraldehyde as solid carriers for sensitizing agents and uses of sensitized unicellular organisms | |
| US5637472A (en) | Hydrazine derivatized cells | |
| EP0655627A2 (en) | Method for direct chemical binding of d-dimer from a biological sample for diagnosing and monitoring thrombolytic and hypercoagulable states | |
| WO1995018375A1 (fr) | Procede et necessaire de detection de constituants sanguins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |